-
Dr. Patrik Frei Delivers a Webinar to Harvard Business School Alumni
On 7th of June 2017, CEO of Venture Valuation, Dr Patrik Frei, delivered a live … Read more
-
Interviews with leading Life Sciences companies: GeNeuro SA
By leveraging expertise it has built up over decades in the HERV medical research and … Read more
-
RESI Conference June 2017- Deal and Product Valuations Workshop
Dr. Patrik Frei, Venture Valuation CEO and a worldwide known expert in life sciences company and … Read more
-
New Record in Valuation of Life Sciences Companies and Products
Zurich / Singapore / Boston, March 2017 – Venture Valuation is looking back to a … Read more
-
Interviews with leading Life Sciences companies: ObsEva SA
ObsEva is specialized in re energizing women’s reproductive and pregnancy therapeutics that have been overlooked … Read more
-
Valuation and HealthTech in Asia
RESI Conference, San Francisco January 2017, 23 pages Valuation and HealthTech in Asia, RESI (Jan … Read more
-
What is the value of a deal?
Venture Valuations Dr. Aitana Peire and Dr. Patrik Frei have published an article “What is … Read more
-
Life Sciences in Europe Report – Smart Site Selection
Zurich / Singapore, June 2016 – Venture Valuation together with KPMG and its new partner … Read more
-
Life Sciences clusters in Europe Report 2016
Venture Valuation together with KPMG and EuropaBio has published its most recent report at BIO … Read more
-
Interviews with leading Life Sciences companies: Oncolys BioPharma Inc.
Co-founded with Prof. Toshiyoshi Fujiwara1, the inventor of the telomerase specific oncolytic adenovirus technology, Oncolys … Read more